Dnazymes as novel therapeutics

International Journal of Pharma and Bio Sciences

Volumn 2, Issue 4, 2011, Pages 161-173

  Babunageswararao, K ^a   Ramakrishna, R ^b   Kamal Kumar, P D ^c   Sameer, Syed ^d  

^a BANARAS HINDU UNIVERSITY   (India)

^b BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

^c JSS COLLEGE OF PHARMACY   (India)

^d Nalanda College of Pharmacy   (India)

Author keywords

Cardiovascular; DNAzymes; Ribozymes; Tumerogenic

Indexed keywords

DEOXYRIBOZYME; EARLY GROWTH RESPONSE FACTOR 1; HAMMERHEAD RIBOZYME; PROTEIN C JUN; THIOREDOXIN INTERACTING PROTEIN; UROKINASE; UROKINASE RECEPTOR; VANILLOID RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; BRAIN DISEASE; DNA DEGRADATION; DNA DETERMINATION; DNA STRUCTURE; DRUG MECHANISM; DRUG STRUCTURE; DRUG TARGETING; ELECTROCHEMICAL DETECTION; HEART MUSCLE ISCHEMIA; HUMAN; MUSCLE DISEASE; NANOTECHNOLOGY; NEOINTIMA; NONHUMAN; PAIN; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; REVIEW; STRUCTURE ANALYSIS; WASTE WATER MANAGEMENT;

EID: 84855516392     PISSN: None     EISSN: 09756299     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Bhindi R, Fahmy R G, Lowe HC, Chesterman C N, Dass C R, Cairns M J et al. Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies. Am J Pathol, 171:1079-1088, (2007).
2. Sen D. and Geyer, C. R. DNA enzymes. Curr. Opin. Chem. Biol, 2: 680-687, (1998).
3. Stein CA. Controversies in the cellular pharmacology of oligodeoxynucleotides. Ciba Found Symp, 209:79-89,(1997).
4. Silverman S. K. DNAzymes- DNA catalyst for bioorganic chemistry. Org. Biomol. Chem., 2: 2701, (2004).
5. Breaker R. R. Making catalytic DNAs. Science, 290: 2095-2096, (2000).
6. Santoro S.W. and Joyce, G. F. A general purpose RNA cleaving DNAzyme. Proc. Natl Acad. Sci. USA, 94:4262-4266, (1997).
7. Sun L.-Q., Cairns, M. J., Saravolac, E.G., Baker, A. and Gerlach, W.L. Catalytic nucleic acids: from lab to applications. Pharmacol. Rev, 52:325-347, (2000).
8. Santoro S.W. and Joyce, G.F. Mechanism and utility of an RNA cleaving DNA enzyme. Biochemistry, 37: 13330-13342, (1998).
9. Finkel E. DNA cuts its teeth as an enzyme. Science, 286: 2441-2442,(1999).
10. Dass C.R., Saravolac, E.G., Li, Y. and Sun, L.Q. Cellular uptake, distribution and stability of 10-23 Deoxyribozymes. Antisense Nucleic Acid Drug Dev, 12: 289-299, (2002).
11. Emilsson G.M. and Breaker, R.R. (2002) Deoxyribozymes: New activities and new applications. Cell. Mol. Life Sci, 59: 596-607, (2002).
12. Kong X.-D., Zhu, S.-Z., Gou, X.-J., Wang, X.-P., Zhang, H.-Y. and Zhang, J. A circular RNA-DNA enzyme obtained by in vitro selection. Biochem. Biophys. Res. Commun, 292: 1111-1115, (2002).
13. Kurreck, J., Bieber, B., Jahnel, R. and Erdmann, V. A. Comparative study of DNA enzymes and r ibozymes against the same full-length messenger RNA of the vanilloid receptor subtype I. J. Biol. Chem, 277: 7099-7107, (2002).
14. Khachigian L.M. DNAzymes: cutting a path to a new class of therapeutics. Curr. Opin. Mol. Ther, 4: 119-121, (2002).
15. Steffen Schubert, Volker A. Eadmann and Jens Kurreck, RNA cleaving '10-23' DNAzymes with enhanced stability and activity, Nucleic Acids Research, 31:5982-5992,(2003).
16. Kurreck, J. Antisense technologies-improvement through novel chemical modifications. Eur. J. Biochem, 270:1628-1644,(2003).
17. Vester,B., Lundberg,L.B., Sorensen,M.D., Babu,B.R., Douthwaite,S. and Wengel,J. LNAzymes: incorporation of LNA-type monomers into DNAzymes markedly increases RNA cleavage. J. Am. Chem. Soc, 124:13682-13683,(2002).
18. V. L. Benson, L. M Kachigian, H, C. Lowe, DNAzymes and cardiovascular disease, British Journal of Pharmacology,154:741-748,(2008).
19. Santiago FS, Atkins DG, Khachigian LM. Vascular smooth muscle cell proliferation and regrowth after mechanical injury in vitro are Egr-1/NGFI-A-dependent. Am J Pathol, 155: 897-905, (1999a).
20. Santiago FS, Lowe HC, Day FL, Chesterman CN, Khachigian LM. Early growth response factor-1 induction by injury is triggered by release and paracrine activation by fibroblast growth factor-2. Am J Pathol, 154: 937-944,(1999b).
21. Zhang G, Dass CR, Sumithran E, Di Girolamo N, Sun LQ, Khachigian LM. Effect of deoxy ribozymes targeting c-Jun on solid tumor growth and angiogenesis in rodents. J Natl Cancer Inst,96: 683-696,(2004).
22. Fahmy RG, Waldman A, Zhang G, Mitchell A, Tedla N, Cai H et al. Suppression of vascular permeability and inflammation by targeting of the transcription factor c-Jun. Nat Biotechnol, 24:856- 863, (2006).
23. Xiang G, Seki T, Schuster MD, Witkowski P, Boyle AJ, See F et al. Catalytic degradation of vitamin D up-regulated protein-1 mRNA enhances cardiomyocyte survival and prevents left ventricular remodeling after myocardial ischemia. J Biol Chem, 280: 39394-39402, (2005b).
24. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB et al. Tumor necrosis factor- alpha and tumor necrosis factor receptors in the failing human heart. Circulation 93:704-711, (1996).
25. Leizang, Warren J.Gasper, Sanfold A. Strass, Olga BIoffe, Myrtle A.Davis and Ajames Mixson, Angiogenic inhibition mediated by a DNAzyme that targets vascular endothelial growth factor receptor-2, Cancer Research, 62: 5463-5469,(2002).
26. Majid Kabuli, John Ahman,Liu Yin and Khamid Tobal, Targeting PML/RARα transcript with DNAzyme results in reduction of proliferation and induction of apoptosis in APL cells, The Hematology Journal, 5: 426-433, (2004)
27. Matsushita H, Kizaki M, Kobayashi H, Ueno H, MutoA, Takayama N et al. Restoration of retinoid ensitivity by MDR1 ribozymes in retinoic acid-resistant myeloid leukaemia cells. Blood, 91: 2452-2458, (1998).
28. Unwalla H, Banerjea AC. Inhibition of HIV-1 gene expression by novel macrophagetropic DNA enzymes targeted to cleaveHIV-1TAT/REVRNA. Biochemical J, 357:147-155, (2001).
29. Beck J, Nassal M. Efficient hammerhead ribozyme mediated cleavage of the structured hepatitis B virus encapsidation signal in vitro and in cell extracts, but not in intact cells. Nucleic Acid Res, 23: 4954-4962, (1995).
30. Khachigian LM, Fahmy RG, Zhang G, Bobryshev YV, Kaniaros A. c-Jun regulates vascular smooth muscle cell growth and neointima formation after arterial injury. Inhibition by a novel DNA enzyme targeting c-jun. J Biol Chem, 277: 22985-22991, (2002).
31. Sandanayaka V.P. and Prashad, A.S. Resistance to beta-lactam antibiotics: structure and mechanism based design of beta-lactamase inhibitors. Curr. Med. Chem, 9: 1145-1165, (2002).
32. I. Ihara, Y. Maruo, S. Takenaka and M. Makoto, Nucleic Acids Res, 24: 4273, (1996).
33. Li Y et al. A Complex RNA - Cleaving DNAzyme That Can Efficiently Cleave a Pyrimidine- Pyrimidine Junction, J. Mol. Biol, 400:689-701, (2010).
34. Caterina, M.J., Schumacher, M.A., Tominaga, T.A., Rosen, T.A., Levine, J.D. and Julius, D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature, 389: 816-824,(1997).
35. Yen,L., Strittmatter, S.M. and Kalb, R.G. Sequence-specific cleavage of Huntingtin mRNA by catalytic DNA. Ann. Neurol, 46: 366-373,(1999).
36. Thirstrup D and Baird G S. Histochemical application of a peroxidase DNAzyme with a covalently attached Hemin Cofactor. Anal. Chem, 82: 2498-2504, (2010).
37. Mastroyiannopoulos N P et al. The Application of Ribozymes and DNAzymes in Muscle and Brain. Molecules, 15:5460-5472, (2010).
38. Thomson, J.B., Tusch l,T. and Eckstein,F. The hammerhead ribozyme. In Eckstein, F. and Lilley, D.M.J.(eds), Catalytic RNA. Springer-Verlag, Berlin, Germany,173-196,(1996).
39. Abraham, W.-R., B. Nogales, P. N. Golyshin, D. H. Piper, and K. N. Timmis. Polychlorinated biphenyl -degrading microbial communities in soils and sediments. Curr. Opin. Microbiol, 5: 246-253, (2002).
40. Furukawa, K., H. Suenaga, and M. Goto.Biphenyl dioxygenases: functional versatilities and directed evolution. J. Bacteriol, 186: 5189-5196, (2004).
41. Nogales, B., E. R. B. Moore, E. Llobet-Brossa, R. Rossello-More, R., Amann, and K. N. Timmis. Combined use of 16S ribosomal DNA and 16S rRNA to study the bacterial community of Polychlorinated biphenyl-polluted soil. Appl. Environ. Microbiol, 67: 1874-1884, (2001).
42. Poulsen, L., G. Ballard, and D. A. Stahl. Use of rRNA fluorescence in situ hybridization for measuring the activity of single cells in young and established biofilms. Appl. Environ. Microbiol. 29: 1354-1360,(1993).
43. McKillip, J. L., L. A. Jaykus, and M. Drake. rRNA stability in heat killed and UV-irradiated enterotoxigenic Staphylococcus aureus and Escherichia coli O157:H7. Appl. Environ. Microbiol. 64: 4264-4268, (1998).
44. Wilson, M. S., C. Bakerman, and E. L. Madsen. In situ, real-time catabolic gene expression: extraction and characterization of naphthalene dioxygenase mRNA transcripts from groundwater. Appl. Environ. Microbiol. 65: 80-87, (1999).
45. Wagner, M., R. Amann, P. Kampfer, B. Assmus, A. Hartmann, P. Hutzler, N. Springer, and K. H. Schleifer. Identification and in situ detection of gram-negative filamentous bacteria in activated sludge. Syst. Appl. Microbiol., 17: 405-417, (1994).
46. Hikaru Suenaga, Rui Liu, Yuko Shiramasa and Takahiro Kanagawa, Novel approach to quantitative detection of specific rRNA in a microbial community using catalytic DNA, Applied and Environmental Microbiology, 71(2005),4879-4884.
47. Lu Y. and Liu J. Functional DNA nanotechnology: emerging applications of DNAzymes and aptamers. Current opinion in Biotechnology,17: 580-588,(2006).